BIOLASE, Inc.
BIOL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.4% | 23.7% | 72% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34% | 32.8% | 42.2% | 27.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -31.4% | -52.2% | -34.4% | -60.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -42% | -59.1% | -41.2% | -73.9% |
| EPS Diluted | -16.14 | -413.19 | -273.41 | -688.19 |
| % Growth | 96.1% | -51.1% | 60.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |